Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Association between leukocyte telomere length and vascular dementia and cancer mortality in an elderly population.

Chen C, Upton C, Braidy N, Khalil J, Fang ZM, Xu YH, Chan DK.

J Am Geriatr Soc. 2014 Jul;62(7):1384-6. doi: 10.1111/jgs.12910. No abstract available.

PMID:
25039510
[PubMed - indexed for MEDLINE]
2.

Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.

Ko E, Jung G.

Biochem Biophys Res Commun. 2014 May 2;447(2):358-63. doi: 10.1016/j.bbrc.2014.04.022. Epub 2014 Apr 13.

PMID:
24732358
[PubMed - indexed for MEDLINE]
3.

Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.

Dogeas E, Karagkounis G, Heaphy CM, Hirose K, Pawlik TM, Wolfgang CL, Meeker A, Hruban RH, Cameron JL, Choti MA.

J Am Coll Surg. 2014 Apr;218(4):628-35. doi: 10.1016/j.jamcollsurg.2014.01.001. Epub 2014 Jan 10.

PMID:
24655849
[PubMed - indexed for MEDLINE]
4.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

PMID:
24627273
[PubMed - indexed for MEDLINE]
5.

Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis.

Girinsky T, M'Kacher R, Lessard N, Koscielny S, Elfassy E, Raoux F, Carde P, Santos MD, Margainaud JP, Sabatier L, Ghalibafian M, Paul JF.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):59-66. doi: 10.1016/j.ijrobp.2014.01.021. Epub 2014 Mar 7.

PMID:
24613809
[PubMed - indexed for MEDLINE]
6.

Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.

Cai H, Kumar N, Bagheri HC, von Mering C, Robinson MD, Baudis M.

BMC Genomics. 2014 Jan 29;15:82. doi: 10.1186/1471-2164-15-82.

PMID:
24476156
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL.

J Pathol. 2014 Mar;232(4):473-81. doi: 10.1002/path.4315.

PMID:
24338723
[PubMed - indexed for MEDLINE]
8.

Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.

Onodera Y, Nam JM, Bissell MJ.

J Clin Invest. 2014 Jan 2;124(1):367-84. doi: 10.1172/JCI63146. Epub 2013 Dec 9.

PMID:
24316969
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Liu JY, Qian D, He LR, Li YH, Liao YJ, Mai SJ, Tian XP, Liu YH, Zhang JX, Kung HF, Zeng YX, Zhou FJ, Xie D.

Mol Cancer. 2013 Nov 23;12(1):148. doi: 10.1186/1476-4598-12-148.

PMID:
24268029
[PubMed - indexed for MEDLINE]
Free Article
10.

Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression.

Panero J, Stanganelli C, Arbelbide J, Fantl DB, Kohan D, García Rivello H, Rabinovich GA, Slavutsky I.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):134-9. doi: 10.1016/j.bcmd.2013.10.002. Epub 2013 Nov 14.

PMID:
24239198
[PubMed - indexed for MEDLINE]
11.

G-quadruplexes as potential therapeutic targets for embryonal tumors.

Shalaby T, Fiaschetti G, Nagasawa K, Shin-ya K, Baumgartner M, Grotzer M.

Molecules. 2013 Oct 10;18(10):12500-37. doi: 10.3390/molecules181012500. Review.

PMID:
24152672
[PubMed - indexed for MEDLINE]
Free Article
12.

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.

Marinoni I, Kurrer AS, Vassella E, Dettmer M, Rudolph T, Banz V, Hunger F, Pasquinelli S, Speel EJ, Perren A.

Gastroenterology. 2014 Feb;146(2):453-60.e5. doi: 10.1053/j.gastro.2013.10.020. Epub 2013 Oct 19.

PMID:
24148618
[PubMed - indexed for MEDLINE]
13.

Nutriomes and personalised nutrition for DNA damage prevention, telomere integrity maintenance and cancer growth control.

Fenech MF.

Cancer Treat Res. 2014;159:427-41. doi: 10.1007/978-3-642-38007-5_24. Review.

PMID:
24114494
[PubMed - indexed for MEDLINE]
14.

Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.

Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, Chen PX, Armitage JO.

Cancer Biol Ther. 2013 Dec;14(12):1077-88. doi: 10.4161/cbt.26342. Epub 2013 Oct 18.

PMID:
24025414
[PubMed - in process]
15.

AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer.

Sasaki T, Kuniyasu H, Luo Y, Kitayoshi M, Tanabe E, Kato D, Shinya S, Fujii K, Ohmori H, Yamashita Y.

Pathobiology. 2014;81(1):36-41. doi: 10.1159/000351721. Epub 2013 Aug 21.

PMID:
23969493
[PubMed - indexed for MEDLINE]
16.

The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.

Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-Grez H, Böhm-Steuer B, Bröcker EB, Mauch C, Utikal J, Hartschuh W, Purdie KJ, Boukamp P.

Oncogene. 2014 Jul 3;33(27):3506-18. doi: 10.1038/onc.2013.323. Epub 2013 Aug 19.

PMID:
23955078
[PubMed - indexed for MEDLINE]
17.

Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.

Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH.

Hepatology. 2014 May;59(5):1912-20. doi: 10.1002/hep.26655. Epub 2014 Mar 27.

PMID:
23907815
[PubMed - indexed for MEDLINE]
18.

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK.

Cancer Discov. 2013 Oct;3(10):1130-41. doi: 10.1158/2159-8290.CD-13-0135. Epub 2013 Jun 18.

PMID:
23779129
[PubMed - indexed for MEDLINE]
19.

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.

Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A.

Mod Pathol. 2013 Nov;26(11):1425-32. doi: 10.1038/modpathol.2013.90. Epub 2013 Jun 14.

PMID:
23765250
[PubMed - indexed for MEDLINE]
20.

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.

Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K.

Acta Neuropathol. 2013 Aug;126(2):267-76. doi: 10.1007/s00401-013-1141-6. Epub 2013 Jun 14.

PMID:
23764841
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk